Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...

It will take years to transform business, but the journey begins now. by Marco Iansiti and Karim R. Lakhani Contracts, transactions, and the records of them are among the defining structures in our ...

Guest: Ben Burgis is a philosophy professor at Rutgers University, a columnist for Jacobin magazine, the host of the YouTube show and podcast Give Them An Argument, and the author of several books, ...